Instil Bio
Craig Kessler has extensive work experience in the IT industry. Craig currently holds the position of Sr. Director, Global Head of IT Infrastructure, Architecture, Security and Operations at Instil Bio since November 2020. Before joining Instil Bio, they worked at Kite Pharma, Inc. as Senior Director, IT Infrastructure and Operations from November 2015 to November 2020. Additionally, Craig has held consultant roles at SCV Technology Group LLC, where they provided project management and technology consulting services, and Prism Technology Group, Inc., specializing in strategic planning and management consulting for IT organizations. Prior to that, they served as the Director of Enterprise Engineering at FedEx Kinko's, overseeing the design, build, and operation of the technology infrastructure to support the company's growth and subsequent acquisition by FedEx. Craig began their career at IBM Global Services, where they worked as a Consultant and System Programmer.
Craig Kessler earned a Bachelor of Science degree in Computer Science from California State University, Northridge. Craig attended the university from 1981 to 1985.
This person is not in any offices
Instil Bio
1 followers
Instil Bio is a cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of solid tumor cancers. TIL are a patient’s own T cells harvested from the patient’s tumor, which are then expanded and reinfused into the patient to target and kill cancer cells. The company is advancing its proprietary manufacturing expertise, technology, and data into clinical trials, including a planned registrational study with its lead candidate and a first-in-human study of its next-generation engineered TIL. The company is led by world-class cell therapy experts and backed by premier global institutional investors. Instil is located in the greater Los Angeles area with additional manufacturing and research facilities in Manchester, UK.